2023

1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

   Multiple Sclerosis and Related Disorders, Vol. 75

2. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

   Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193